Heron Therapeutics (HRTX) Construction in Progress (2016 - 2024)
Historic Construction in Progress for Heron Therapeutics (HRTX) over the last 11 years, with Q4 2024 value amounting to $2.6 million.
- Heron Therapeutics' Construction in Progress fell 5873.02% to $2.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.6 million, marking a year-over-year decrease of 5873.02%. This contributed to the annual value of $2.6 million for FY2024, which is 5873.02% down from last year.
- Heron Therapeutics' Construction in Progress amounted to $2.6 million in Q4 2024, which was down 5873.02% from $6.3 million recorded in Q4 2023.
- In the past 5 years, Heron Therapeutics' Construction in Progress ranged from a high of $15.9 million in Q4 2021 and a low of $2.6 million during Q4 2024
- Moreover, its 5-year median value for Construction in Progress was $6.3 million (2023), whereas its average is $8.9 million.
- In the last 5 years, Heron Therapeutics' Construction in Progress crashed by 6603.77% in 2022 and then soared by 1666.67% in 2023.
- Over the past 5 years, Heron Therapeutics' Construction in Progress (Quarter) stood at $14.1 million in 2020, then rose by 12.77% to $15.9 million in 2021, then tumbled by 66.04% to $5.4 million in 2022, then grew by 16.67% to $6.3 million in 2023, then tumbled by 58.73% to $2.6 million in 2024.
- Its Construction in Progress was $2.6 million in Q4 2024, compared to $6.3 million in Q4 2023 and $5.4 million in Q4 2022.